ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736157 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736157; 2) Community: the network communities that were significantly associated with the response to NSC 736157; 3) Molecule: the relationships between components within communities and NSC 736157; 4) MDR: the compounds that were significantly associated with the NSC 736157.

NSC Compound Enrichment Correlation
NSC 689222 Null 0.0202245331784474 -0.15053988
NSC 690042 6H-Pyrido[2,3,4-kl]acridin-6-one, 4-methoxy- 0.0202245331784474 -0.074581106
NSC 697569 Null 0.0202245331784474 -0.20730716
NSC 718191 Null 0.0202245331784474 -0.29026403
NSC 720340 Null 0.0202245331784474 -0.036963416
NSC 722779 dabequine 0.0202245331784474 0.1555863
NSC 724827 1,4-di-N-oxide-6,7-difluoro-2-ethylcarbonyl-3-trifluoromethy lquinoxaline 0.0202245331784474 -0.072473568
NSC 727985 NSC 708781 incorporated in micelles, 0.55% (w/w) of drug 0.0202245331784474 -0.22503771
NSC 209835 [11]Cytochalasa-6(12),13,19-triene-1,17-dione, 21-(acetyloxy)-7,18-dihydroxy-16,18-dimethyl-10-phenyl-, (7S,13E,16S,18R,19E,21R)- (9CI) 0.0202245331784477 0.40191725
NSC 271674 Carboxyphthalatoplatinum 0.0202245331784477 -0.10927828
Total:90  Current:36    [First] [Prev] [Next] [Last]